$255.30+$0.98 (+0.39%)as of market close, Jul 24, 2026
CME — CME Group Inc. stock price, chart and key statistics
Key stats
Price data
- Price
- $255.30
- Change YTD
- -5.33%
- Market cap
- 92.2B
- Enterprise value
- 90.1B
- Shares outstanding
- 361.3M
- 52W low
- $218.31
- 52W high
- $329.16
- From 52W high
- -22.44%
- From 52W low
- +16.94%
- 52W range
- 33%
- Beta
- 0.28
Volume
- Rel volume
- 0.74×
- 30D volume
- 3.6M
- 30D $ vol
- 873M
Fundamentals
- Sales (ttm)
- 6.8B
- Sales/share
- $18.75
- EPS (ttm)
- $11.76
- FCF (ttm)
- 4.2B
- FCF/share
- $11.66
- Book value/share
- $73.41
- Net margin
- 63.05%
- ROE
- 16.10%
- ROA
- 2.19%
- Current ratio
- 1.02
Growth (CAGR, ttm) · 10Y
- Sales
- +6.81%
- Net income
- +12.77%
- FCF
- +10.77%
- Shares
- +0.65%
Per-share growth (CAGR, ttm) · 10Y
- EPS
- +11.99%
- Sales/share
- +6.12%
- FCF/share
- +10.05%
- Book value/share
- +1.67%
- Dividend/share
- +0.20%
- Price
- +9.63%
- Total return
- +13.88%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 21.6×
- Fwd P/E
- 19.6×
- P/S (ttm)
- 13.6×
- P/B (mrq)
- 3.5×
- P/FCF (ttm)
- 21.9×
- EV/EBITDA (fy)
- 20.8×
- EV/Sales (ttm)
- 13.3×
- FCF yield (ttm)
- 4.57%
- Dividend yield (fwd)
- 2.04%
- Dividend/share (fwd)
- $5.20
- Buyback yield (ttm)
- 0.00%
- Shareholder yield (ttm)
- 4.42%
Vs own 10Y history
- P/E
- 12th
- P/S
- 40th
- P/B
- 90th
- P/FCF
- 11th
Bar = where today's multiple sits in CME's own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance
1D
+0.39%
1W
+4.18%
1M
+10.20%
3M
-10.57%
YTD
-5.33%
1Y
-7.66%
5Y
+21.96%
Financial statements
Open full CME financials →Related Financials
1MCME Group Inc. (CME) trades at $255.30 with a live price and an interactive chart covering 23+ years of daily price history, plus key valuation metrics. ChartRow also publishes CME's financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full CME financial statements →